You are currently using an unsupported browser which could affect the appearance and functionality of this website. Please consider upgrading to the latest version or using alternatives such as Mozilla Firefox, Google Chrome or Microsoft Edge.

Management of Beta Thalassaemia in Pregnancy (Green-top Guideline No. 66)


In this guideline, thalassaemia major women are those who require more than seven transfusion episodes per year and thalassaemia intermedia women are those needing seven or fewer transfusion episodes per year or those who are not transfused. Women who are thalassaemia carriers do not require transfusion.

This guideline includes preconceptual, antenatal, intrapartum and postnatal management and contraception in both primary and secondary care settings. It does not cover screening, as the British Committee for Standards in Haematology has published guidelines for screening and diagnosis of thalassaemias.

COVID disclaimer

This guideline was developed as part of the regular programme of Green-top Guidelines, as outlined in our document Developing a Green-top Guideline: Guidance for developers (PDF), and prior to the emergence of COVID-19.

Version history

This is the first edition of this guideline.

The British Society for Haematology have agreed to take over and update this guideline. This version will remain valid until the publication of new guidance by BSH.

Developer declaration of interests

Available on request.

This page was last reviewed 27 March 2014.